Virbac Announces Total Number of Shares and Voting Rights

Key Information on Shares and Voting Rights
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS
This article provides crucial information regarding the total shares and voting rights for Virbac, relevant for shareholders and investors. The details presented comply with Article 223-16 of the General regulations of the French Financial Market Authority.
Trading Venue: Euronext Paris
Compartiment A
ISIN code: FR0000031577
Overview of Shares
The current total number of shares representing the share capital is a significant aspect of Virbac's standing in the market. As of the latest count, Virbac has a total of 8,390,660 shares issued. This figure is essential for stakeholders who monitor market shipments and trading activities.
Understanding Voting Rights
The voting rights associated with these shares are equally crucial for shareholders. It is vital to emphasize that gross voting rights total 12,706,453, which includes all eligible shares contributing to shareholder votes. However, it's important to note the net total of voting rights is slightly lower, at 12,693,617. This discrepancy accounts for shares that do not confer voting privileges.
Annual Reporting Compliance
Virbac's transparency in reporting shares and voting rights reaffirms its commitment to regulatory compliance and shareholder communication. Investors look for such reports to make informed decisions based on the company's performance and governance.
The Importance of Accurate Reporting
Accurate declaration of shares and voting rights aids in maintaining investor trust. Stakeholders can assess their voting power in corporate matters, ensuring that decision-making reflects the ownership structure.
Contact Information for Shareholders
For any inquiries regarding shares or voting rights, shareholders can contact Virbac directly. The corporate finance department is available for questions and clarifications.
VIRBAC: Shaping the Future of Animal Health
NYSE Euronext - Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel. 33 4 92 08 71 32
Frequently Asked Questions
What is the total number of shares for Virbac?
The total number of shares for Virbac is currently 8,390,660.
What are the total voting rights for Virbac?
The gross total of voting rights is 12,706,453, while the net total is 12,693,617.
Why is the distinction between gross and net voting rights important?
This distinction is essential as it provides insight into the actual voting power available to shareholders, factoring in shares that do not hold voting rights.
Where can I find more information about Virbac?
More information can be found on their official website or by contacting their corporate finance department directly.
What is the ISIN code for Virbac?
The ISIN code for Virbac is FR0000031577.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.